Scientists seek to unravel hidden subtypes of Sepsis-Linked lung failure

NCT ID NCT07281911

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will closely monitor 180 adults with sepsis-related acute respiratory distress syndrome (ARDS) who are on breathing machines. Researchers will take fluid samples from the lungs and blood at several time points to measure inflammation and injury markers. The goal is to identify distinct biological and physical patterns of the disease, which could eventually help doctors tailor treatments to each patient's specific condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could identify distinct subtypes of sepsis-related ARDS, paving the way for more personalized treatments in the future.
What could go wrong
This is an early observational study, not a treatment trial. It will not directly test any therapy, and the findings may not lead to immediate clinical changes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE HYPOXEMIC RESPIRATORY FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Universitari Vall d'Hebron

    Barcelona, 08035, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.